- Article
TDMQ20 as A Drug Candidate for Wilson’s Disease: Comparison with D-Penicillamine, Trientine, and Tetrathiomolybdate In Vitro and In Mice
- Yingshan Zhu,
- Weiling Peng,
- Guangwei Liu,
- Longxin Li,
- Zikang Zhou,
- Michel Nguyen,
- Anne Robert,
- Yan Liu and
- Bernard Meunier
Background/Objectives: The lifelong treatment of Wilson’s disease (WD) currently relies on copper chelators with relatively poor metal specificity, which frequently exhibit serious adverse effects. There is a real medical need for a specific co...

